Danaher earnings were $4.0B for the trailing 12 months ending Jun 26, 2026, with 19.5% growth year over year. The latest DHR earnings report on Jun 26, 2026 announced Q2 2026 earnings of $870.0M, down 15.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, DHR reported annual earnings of $3.6B, with -7.3% growth.
DHR past earnings growth
How has DHR's earnings growth performed historically?
On DHR's earnings call on Jul 21, 2026, Danaher (NYSE: DHR) reported Q2 2026 earnings per share (EPS) of $1.23, up 59.74% year over year. Total DHR earnings for the quarter were $870.00 million. In the same quarter last year, Danaher's earnings per share (EPS) was $0.77.
As of the last Danaher earnings report, Danaher is currently profitable. Danaher's net profit (also called net income) for the twelve months ending Jun 26, 2026 was $4.00 billion, a 17.32% increase year over year.
What was DHR's earnings growth in the past year?
As of Danaher's earnings date in Jul 21, 2026, Danaher's earnings has grown 19.45% year over year. This is 4.92 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 14.53%. DHR earnings in the past year totalled $4.00 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.